NEO

NeoGenomics, Inc.

About NEO

NeoGenomics, Inc. operates a network of cancer-focused testing laboratories. The Company operates through two segments: the Clinical Services Segment and the Pharma Services Segment. The Clinical Services segment provides various clinical testing services to community-based pathology practices, oncology practices, hospital pathology labs, reference labs, and academic centers with reimbursement from various payers, including client direct billing, commercial insurance, Medicare and other government payers, and patients. The Pharma Services segment supports pharmaceutical firms in their drug development programs by providing testing services and data analytics for clinical trials and research. It offers testing services, which include cytogenetics, fluorescence in-situ hybridization (FISH), flow cytometry, immunohistochemistry (IHC) and digital imaging, molecular testing and morphologic analysis. It operates testing laboratories in United States, Europe and Asia.

Buy US stocks in Australia starting with NEO. Open an account and start investing today!

Market Capitalisation

$1.48B

Price-earnings ratio

Dividend yield

0.00%

Volume

High today

$12.50

Low today

$11.71

Open price

$0.00

52-week high

$23.78

52-week low

$6.00

NEO FAQs

How much is one share of NeoGenomics, Inc.?

One share of NeoGenomics, Inc. is valued at $11.78.

What is the ticker symbol for NeoGenomics, Inc.?

The ticker symbol for NeoGenomics, Inc. is NEO.

How do I buy NEO shares in Australia?

To buy NEO stocks in Australia you'll need to open an account with a broker like Stake.
To do so follow these steps:

Sign up in minutes, all you need is some I.D.
Choose Stake Wall St
Deposit directly into your Stake wallet and you're ready to invest in NEO

What is the market capitalisation of NeoGenomics, Inc. NEO?

As of 07/02/2023 NeoGenomics, Inc. has a market cap of $1.5B.

What is the 52-week high for NeoGenomics, Inc. stock?

The NeoGenomics, Inc. 52-week high stock price is $23.78.

What is the 52-week low for NeoGenomics, Inc. stock?

The NeoGenomics, Inc. 52-week low stock price is $6.00.

Related Stocks

This does not constitute financial advice. You should do your own research before making an investment decision. Past performance is not a reliable indication of future performance. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.